872 related articles for article (PubMed ID: 10675220)
21. The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated malignant peripheral nerve sheath tumors.
Higham CS; Dombi E; Rogiers A; Bhaumik S; Pans S; Connor SEJ; Miettinen M; Sciot R; Tirabosco R; Brems H; Baldwin A; Legius E; Widemann BC; Ferner RE
Neuro Oncol; 2018 May; 20(6):818-825. PubMed ID: 29409029
[TBL] [Abstract][Full Text] [Related]
22. [Utility of 18 FDG positon emission tomography in detection of sarcomatous transformation in neurofibromatosis type 1].
Bensaid B; Giammarile F; Mognetti T; Galoisy-Guibal L; Pinson S; Drouet A; Combemale P
Ann Dermatol Venereol; 2007 Oct; 134(10 Pt 1):735-41. PubMed ID: 17978710
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive anatomical and functional imaging in patients with type I neurofibromatosis using simultaneous FDG-PET/MRI.
Reinert CP; Schuhmann MU; Bender B; Gugel I; la Fougère C; Schäfer J; Gatidis S
Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):776-787. PubMed ID: 30535768
[TBL] [Abstract][Full Text] [Related]
24. Neurofibroma and schwannoma.
Ferner RE; O'Doherty MJ
Curr Opin Neurol; 2002 Dec; 15(6):679-84. PubMed ID: 12447105
[TBL] [Abstract][Full Text] [Related]
25. Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours.
Brenner W; Friedrich RE; Gawad KA; Hagel C; von Deimling A; de Wit M; Buchert R; Clausen M; Mautner VF
Eur J Nucl Med Mol Imaging; 2006 Apr; 33(4):428-32. PubMed ID: 16404595
[TBL] [Abstract][Full Text] [Related]
26. The value of 18F-FDG PET/CT in patient with neurofibromatosis type 1: A case report and literature review.
Ren J; Yang G; Zhou J; Fu Z
Medicine (Baltimore); 2018 May; 97(20):e10648. PubMed ID: 29768331
[TBL] [Abstract][Full Text] [Related]
27. Comparative effectiveness of 18F-FDG PET/CT versus whole-body MRI for detection of malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
Derlin T; Tornquist K; Münster S; Apostolova I; Hagel C; Friedrich RE; Wedegärtner U; Mautner VF
Clin Nucl Med; 2013 Jan; 38(1):e19-25. PubMed ID: 23242059
[TBL] [Abstract][Full Text] [Related]
28. Radiological manifestations of abdominopelvic nerve tumours seen in neurofibromatosis type 1.
Ozcan HN; Karcaaltincaba M; Oguz B; Haliloglu M
Clin Radiol; 2014 Apr; 69(4):431-5. PubMed ID: 24361143
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients.
Brahmi M; Thiesse P; Ranchere D; Mognetti T; Pinson S; Renard C; Decouvelaere AV; Blay JY; Combemale P
PLoS One; 2015; 10(10):e0138386. PubMed ID: 26445379
[TBL] [Abstract][Full Text] [Related]
30. Utility of positron emission tomography for tumour surveillance in children with neurofibromatosis type 1.
Moharir M; London K; Howman-Giles R; North K
Eur J Nucl Med Mol Imaging; 2010 Jul; 37(7):1309-17. PubMed ID: 20179923
[TBL] [Abstract][Full Text] [Related]
31. Malignant Peripheral Nerve Sheath Tumor.
James AW; Shurell E; Singh A; Dry SM; Eilber FC
Surg Oncol Clin N Am; 2016 Oct; 25(4):789-802. PubMed ID: 27591499
[TBL] [Abstract][Full Text] [Related]
32. Integrated imaging in peripheral nerve lesions in type 1 neurofibromatosis.
Iannicelli E; Rossi G; Almberger M; Drudi FM; Giustini S; Calvieri S; David V
Radiol Med; 2002 Apr; 103(4):332-43. PubMed ID: 12107383
[TBL] [Abstract][Full Text] [Related]
33. Malignant transformation in a sciatic plexiform neurofibroma in Neurofibromatosis Type 1 - imaging features that aid diagnosis.
Chew DCY; Zhao DBH; Sittampalam K; Kumar SK
J Radiol Case Rep; 2020 Dec; 14(12):1-13. PubMed ID: 33717399
[TBL] [Abstract][Full Text] [Related]
34. Retroperitoneal malignant peripheral nerve sheath tumor: evaluation with serial FDG-PET.
Chander S; Westphal SM; Zak IT; Bloom DA; Zingas AP; Joyrich RN; Littrup PJ; Taub JW; Getzen TM
Clin Nucl Med; 2004 Jul; 29(7):415-8. PubMed ID: 15192465
[TBL] [Abstract][Full Text] [Related]
35. Frequent genomic imbalances in chromosomes 17, 19, and 22q in peripheral nerve sheath tumours detected by comparative genomic hybridization analysis.
Koga T; Iwasaki H; Ishiguro M; Matsuzaki A; Kikuchi M
J Pathol; 2002 May; 197(1):98-107. PubMed ID: 12081210
[TBL] [Abstract][Full Text] [Related]
36. Surgery for atypical plexiform neurofibromas of the trunk in NF1 with high standardised uptake value (SUV) in positron-emission tomography (PET) expressing podoplanin: a long-term follow-up.
Friedrich RE; Gawad K; Derlin T; Zustin J; Hagel C
Anticancer Res; 2012 Oct; 32(10):4547-51. PubMed ID: 23060584
[TBL] [Abstract][Full Text] [Related]
37. Symptoms associated with malignancy of peripheral nerve sheath tumours: a retrospective study of 69 patients with neurofibromatosis 1.
Valeyrie-Allanore L; Ismaïli N; Bastuji-Garin S; Zeller J; Wechsler J; Revuz J; Wolkenstein P
Br J Dermatol; 2005 Jul; 153(1):79-82. PubMed ID: 16029330
[TBL] [Abstract][Full Text] [Related]
38. A series of 397 peripheral neural sheath tumors: 30-year experience at Louisiana State University Health Sciences Center.
Kim DH; Murovic JA; Tiel RL; Moes G; Kline DG
J Neurosurg; 2005 Feb; 102(2):246-55. PubMed ID: 15739552
[TBL] [Abstract][Full Text] [Related]
39. Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors.
Beert E; Brems H; Daniëls B; De Wever I; Van Calenbergh F; Schoenaers J; Debiec-Rychter M; Gevaert O; De Raedt T; Van Den Bruel A; de Ravel T; Cichowski K; Kluwe L; Mautner V; Sciot R; Legius E
Genes Chromosomes Cancer; 2011 Dec; 50(12):1021-32. PubMed ID: 21987445
[TBL] [Abstract][Full Text] [Related]
40. Limitations and benefits of FDG-PET/CT in NF1 patients with nerve sheath tumors: A cross-sectional/longitudinal study.
Nishida Y; Ikuta K; Ito S; Urakawa H; Sakai T; Koike H; Ito K; Imagama S
Cancer Sci; 2021 Mar; 112(3):1114-1122. PubMed ID: 33415792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]